Syngene International (BOM:539268) EV-to-EBIT : 40.58 (As of May. 01, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Syngene International EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Syngene International's Enterprise Value is ₹271,050 Mil. Syngene International's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹6,680 Mil. Therefore, Syngene International's EV-to-EBIT for today is 40.58.

The historical rank and industry rank for Syngene International's EV-to-EBIT or its related term are showing as below:

BOM:539268' s EV-to-EBIT Range Over the Past 10 Years
Min: 17.54 Med: 31.46 Max: 55.01
Current: 40.57

During the past 13 years, the highest EV-to-EBIT of Syngene International was 55.01. The lowest was 17.54. And the median was 31.46.

BOM:539268's EV-to-EBIT is ranked worse than
82.73% of 440 companies
in the Biotechnology industry
Industry Median: 8.725 vs BOM:539268: 40.57

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Syngene International's Enterprise Value for the quarter that ended in Mar. 2024 was ₹275,800 Mil. Syngene International's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹6,680 Mil. Syngene International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.42%.

Syngene International EV-to-EBIT Historical Data

The historical data trend for Syngene International's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International EV-to-EBIT Chart

Syngene International Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-EBIT

Get a 7-Day Free Trial

16.92

43.39

46.83

36.35

41.29

Syngene International Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															36.35	45.63	45.39	40.88	41.29

Competitive Comparison of Syngene International's EV-to-EBIT

For the Biotechnology subindustry, Syngene International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syngene International's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Syngene International's EV-to-EBIT falls into.

Syngene International EV-to-EBIT Calculation

Syngene International's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	271050.008	/	6680
	=	40.58

Syngene International's current Enterprise Value is ₹271,050 Mil.
Syngene International's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6,680 Mil.

Syngene International (BOM:539268) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Syngene International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	6680	/	275800.0107
	=	2.42 %

Syngene International's Enterprise Value for the quarter that ended in Mar. 2024 was ₹275,800 Mil.
Syngene International's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6,680 Mil.

Syngene International EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Syngene International's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Syngene International (BOM:539268) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (BOM:539268) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

SYNGENE:India

Address

Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099

Website

https://www.syngeneintl.com

Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (BOM:539268) Headlines

No Headlines